Announcements Trials

Browse Landscape

Phase

Status

Recruiting 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1

Interventions

pembrolizumab 374 Carboplatin 276 Specimen Handling 265 Nivolumab 251 Magnetic Resonance Spectroscopy 246 Cyclophosphamide 240 Cisplatin 214 Paclitaxel 205 Radiotherapy 196 Biopsy 172 Gemcitabine 155 Dexamethasone 150 durvalumab 144 atezolizumab 125 Rituximab 120 Doxorubicin 115 Bevacizumab 114 Lenalidomide 113 Ipilimumab 113 Radiation 110 Pemetrexed 101 Etoposide 101 Docetaxel 101 fludarabine 97 venetoclax 95 Capecitabine 92 Fluorouracil 91 Radiosurgery 90 Prednisone 89 Oxaliplatin 88

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Glutamyl Aminopeptidase × 1 year × Clear all

NCT05415527 2026-01-29

OPTIMOVA

Institut Bergonié

Phase NA Active not recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡